Zevra Therapeutics's total assets for Q1 2025 were $172.71M, a decrease of -3.04% from the previous quarter. ZVRA total liabilities were $131.69M for the fiscal quarter, a -4.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.